3-[2-(Perfluorohexyl)ethoxy]-1,2-epoxypropane Cas:122193-68-4

We are 3-[2-(Perfluorohexyl)ethoxy]-1,2-epoxypropane CAS:122193-68-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


3-[2-(Perfluorohexyl)ethoxy]-1,2-epoxypropane

Synonyms:
3-(3,3,4,4,5,5,6,6,7,7,8,8,8-Tridecafluorooctyloxy)-1,2-epoxypropane
2-(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctoxymethyl)oxirane
 
Molecular Formula: C11H9F13O2
Molecular weight:420.16700
 
Density: 1.57
Boiling point: 218.8ºC at 760 mmHg
Flash point: 92.9ºC
Refractive index: 1.331
Vapor pressure: 0.182mmHg at 25°C

 
Our company is committed to establishing a complete fluorochemical products and technology platform to provide customers with convenient one-stop services. Our products are widely used in the manufacture of new materials, pharmaceutical research and development and the development of new pesticides. The fluorine product categories include fluorine-containing material raw materials, fluorinated reagents, fluorine-containing building blocks, fluorine-containing reagents and fluorine-containing gases for synthesis. Shanghai Fluorine Technology will strive to build a complete industrial chain from fluorine-containing raw material procurement, fluorination technology research and development, fluorine-containing product production, fluorine-containing product storage, fluorine-containing product quality control and fluorine-containing product application.
 



Market News: In Massachusetts, where the bulk of Takeda’s U.S. operations are based since the Shire buyout, the Japanese pharma has been swiftly ramping up its cell therapy ambitions. In September, the company cut the ribbon on a new 24,000-square-foot R&D manufacturing center in Boston, which it said at the time would handle clinical development for three ongoing pipeline programs and two other prospects pegged to enter clinical development by the end of 2021.9,10-dibromopyrazino[2,3-g]quinoxaline manufacturer.The booster campaign, with shots administered by health maintenance organisations, will effectively turn Israel into a testing ground for a third dose before approval by the U.S. Food and Drug Administration (FDA). dimethyl 4-(3-(2-(4-(4-(3-methoxyphenyl)piperidin-1-yl)butanoyl)hydrazine-1-carboxamido)phenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate supplier Case in point: Hansoh Pharma is seeking approvals for its third-generation EGFR inhibitor Ameile (almonertinib) for newly diagnosed EGFR-mutated non-small cell lung cancer. 3H-1,2,4-Triazol-3-one,5-[[3-[4-[6-(1,1-dimethylethyl)-2-(1H-pyrrol-1-yl)-4-pyrimidinyl]hexahydro-1H-1,4-diazepin-1-yl]propyl]thio]-2,4-dihydro-4-methyl- producer

Related Products
Product Name
Doripenem Cas:148016-81-3 View Details
ISOMALT Cas:64519-82-0 View Details
(S)-Sitagliptin Cas:823817-55-6 View Details
2-Aminobenzophenone Cas:2835-77-0 manufacturer Ethyl 2-cyano-4,4-dimethoxybutanoate Cas:773076-83-8 manufacturer Hydroxytyrosol manufacturer Tetrabenzyl Pyrophosphate manufacturer Light Stabilizer 3529 manufacturer